Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Farcet MR"'
Autor:
Chen MH; Viral Vaccine Preventable Diseases Branch, National Center for Immunization & Respiratory Diseases, Centers for Disease Control & Prevention, GA 30333 Atlanta, USA., Perelygina L; Viral Vaccine Preventable Diseases Branch, National Center for Immunization & Respiratory Diseases, Centers for Disease Control & Prevention, GA 30333 Atlanta, USA., Hao L; Viral Vaccine Preventable Diseases Branch, National Center for Immunization & Respiratory Diseases, Centers for Disease Control & Prevention, GA 30333 Atlanta, USA., Beard RS; Viral Vaccine Preventable Diseases Branch, National Center for Immunization & Respiratory Diseases, Centers for Disease Control & Prevention, GA 30333 Atlanta, USA., Lackner C; Global Pathogen Safety, Takeda Manufacturing Austria AG, 1221 Vienna, Austria., Farcet MR; Global Pathogen Safety, Takeda Manufacturing Austria AG, 1221 Vienna, Austria., Karbiener M; Global Pathogen Safety, Takeda Manufacturing Austria AG, 1221 Vienna, Austria., Icenogle J; Viral Vaccine Preventable Diseases Branch, National Center for Immunization & Respiratory Diseases, Centers for Disease Control & Prevention, GA 30333 Atlanta, USA., Kreil TR; Global Pathogen Safety, Takeda Manufacturing Austria AG, 1221 Vienna, Austria.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2024 Apr 09. Date of Electronic Publication: 2024 Apr 09.
Autor:
Farcet MR; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria., Modrof J; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria., Antoine G; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria., Klausen C; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria., Kerschbaum A; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria., Kopp M; Viral Vector Process Design, Kite Pharma, Santa Monica, California, USA., Dehghani H; Operations Technology, Allogene Therapeutics, San Francisco, California, USA., Kreil TR; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria.
Publikováno v:
Biotechnology and bioengineering [Biotechnol Bioeng] 2024 Jan; Vol. 121 (1), pp. 131-138. Date of Electronic Publication: 2023 Oct 19.
Autor:
Pérot P; Pathogen Discovery Laboratory, Institut Pasteur, Université Paris Cité, Paris, France.; Institut Pasteur, Université Paris Cité, The WOAH (OIE) Collaborating Center for the detection and identification in humans of emerging animal pathogens, Paris, France., Da Rocha N; Pathogen Discovery Laboratory, Institut Pasteur, Université Paris Cité, Paris, France.; Institut Pasteur, Université Paris Cité, The WOAH (OIE) Collaborating Center for the detection and identification in humans of emerging animal pathogens, Paris, France., Farcet MR; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria., Kreil TR; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria., Eloit M; Pathogen Discovery Laboratory, Institut Pasteur, Université Paris Cité, Paris, France.; Institut Pasteur, Université Paris Cité, The WOAH (OIE) Collaborating Center for the detection and identification in humans of emerging animal pathogens, Paris, France.; École Nationale Vétérinaire d'Alfort, Université Paris-Est, Maisons-Alfort, France.
Publikováno v:
Transfusion [Transfusion] 2024 Jan; Vol. 64 (1), pp. 16-18. Date of Electronic Publication: 2023 Nov 19.
Autor:
Farcet MR; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria., Lackner C; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria., Schirmer A; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria., Kreil TR; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria.
Publikováno v:
Vox sanguinis [Vox Sang] 2023 Oct; Vol. 118 (10), pp. 906-907. Date of Electronic Publication: 2023 Aug 08.
Autor:
McIntosh D; UK Plasma Action, Petersfield, United Kingdom., Burnouf T; UK Plasma Action, Petersfield, United Kingdom.; Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan.; International PhD Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan., Karbiener M; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria., Farcet MR; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria., Kreil TR; UK Plasma Action, Petersfield, United Kingdom.; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria.
Publikováno v:
Blood transfusion = Trasfusione del sangue [Blood Transfus] 2023 Sep; Vol. 21 (5), pp. 375-377. Date of Electronic Publication: 2023 Feb 24.
Autor:
Polasek D; R&D Pharmaceutical Science, Baxalta Innovations GmbH (part of Takeda), Industriestraße 131, 1220, Vienna, Austria., Flicker A; Global Pathogen Safety, Takeda Manufacturing Austria AG, Benatzkygasse 2-6, 1221, Vienna, Austria. Electronic address: andreas.flicker@takeda.com., Fiedler C; R&D Pharmaceutical Science, Baxalta Innovations GmbH (part of Takeda), Industriestraße 131, 1220, Vienna, Austria., Farcet MR; Global Pathogen Safety, Takeda Manufacturing Austria AG, Benatzkygasse 2-6, 1221, Vienna, Austria., Purtscher M; R&D Pharmaceutical Science, Baxalta Innovations GmbH (part of Takeda), Industriestraße 131, 1220, Vienna, Austria., Kreil TR; Global Pathogen Safety, Takeda Manufacturing Austria AG, Benatzkygasse 2-6, 1221, Vienna, Austria.
Publikováno v:
Biologicals : journal of the International Association of Biological Standardization [Biologicals] 2023 Aug; Vol. 83, pp. 101693. Date of Electronic Publication: 2023 Jul 28.
Autor:
Farcet MR; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria., Karbiener M; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria., Knotzer S; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria., Schwaiger J; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria., Kreil TR; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2022 Oct 17; Vol. 226 (8), pp. 1396-1400.
Autor:
Farcet MR; Global Pathogen Safety, Baxter AG (part of Takeda), Vienna, Austria., Karbiener M; Global Pathogen Safety, Baxter AG (part of Takeda), Vienna, Austria., Schwaiger J; Global Pathogen Safety, Baxter AG (part of Takeda), Vienna, Austria., Ilk R; Global Manufacturing Sciences, Baxter AG (part of Takeda), Vienna, Austria., Kreil TR; Global Pathogen Safety, Baxter AG (part of Takeda), Vienna, Austria.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2022 Oct 17; Vol. 226 (8), pp. 1357-1361.
Autor:
Farcet MR; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria., Schwaiger J; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria., Karbiener M; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria., Kreil TR; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria.
Publikováno v:
Frontiers in medicine [Front Med (Lausanne)] 2022 Aug 02; Vol. 9, pp. 924426. Date of Electronic Publication: 2022 Aug 02 (Print Publication: 2022).
Autor:
Lackner C; Global Pathogen Safety, Takeda Manufacturing Austria AG, Takeda, Benatzkygasse 2-6, 1221, Vienna, Austria., Karbiener M; Global Pathogen Safety, Takeda Manufacturing Austria AG, Takeda, Benatzkygasse 2-6, 1221, Vienna, Austria., Faltner L; Global Pathogen Safety, Takeda Manufacturing Austria AG, Takeda, Benatzkygasse 2-6, 1221, Vienna, Austria., Farcet MR; Global Pathogen Safety, Takeda Manufacturing Austria AG, Takeda, Benatzkygasse 2-6, 1221, Vienna, Austria., Kreil TR; Global Pathogen Safety, Takeda Manufacturing Austria AG, Takeda, Benatzkygasse 2-6, 1221, Vienna, Austria. thomas.kreil@takeda.com.
Publikováno v:
Immunologic research [Immunol Res] 2022 Jun; Vol. 70 (3), pp. 365-370. Date of Electronic Publication: 2022 Mar 09.